生物製程容器市場規模、佔有率、成長分析，按類型、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球生物製程容器市場規模將為21億美元，從2023年的26.3億美元成長到2031年的158.7億美元，預計在預測期間（2024-2031年）成長。 25.20%。

近年來，全球生物程序容器市場呈現顯著擴張。這種成長主要是由於該行業轉向一次性技術，這些技術提高了業務效率、降低了感染風險並簡化了生物製藥生產流程。一次性袋子，也稱為一次性袋子，已成為疫苗、生技藥品和其他醫藥產品生產中必不可少的產品。它的日益普及是市場擴張的一個主要因素。此外，對靈活且具有成本效益的解決方案的需求進一步推動了市場的成長。在生物製藥技術進步和研發活動活性化的支持下，市場預計將繼續發展。主要企業的策略性舉措，例如併購、聯盟、產品線和地理擴張等，對於塑造市場也至關重要。這些措施對於保持競爭優勢和促進生物製程容器產業的持續成長至關重要。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 市場生態系統
• 供應鏈分析
• 案例研究分析
• 監管環境
• 創新矩陣
• 重點投資分析
• 關鍵成功因素
• 競爭程度

生物程序容器市場：按類型

• 市場概況
• 2D生物製程容器
• 3D生物製程容器
• 其他容器及配件

生物製程容器市場：依應用分類

• 市場概況
• 上游過程
• 下游工藝
• 製程開發

生物程序容器市場：依最終用戶分類

• 市場概況
• 製藥和生物製藥公司
• 藥品委外研發機構/藥品受託製造廠商
• 學術/研究機構

按地區分類的生物製程容器市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Sartorius Stedim Biotech（France）
• Thermo Fisher Scientific Inc.（US）
• Danaher Corporation（US）
• Merck KGaA（Germany）
• Saint-Gobain（France）
• Avantor, Inc.（US）
• Parker Hannifin Corporation（US）
• Corning Incorporated（US）
• Entegris, Inc.（US）
• Meissner Filtration Products, Inc.（US）
• Lonza AG（Switzerland）
• Antylia Scientific（US）
• Flexbiosys Inc.（US）
• Michelin Group（France）
• ABEC, Inc.（US）
• Cellexus（UK）
• Keofitt A/S（Denmark）
• Fujimori Kogyo Co., Ltd.（Japan）
• Cesco Bioengineering Co., Ltd.（Taiwan）
• Solida Biotech GmbH（Germany）
• Satake Chemical Equipment Mfg., Ltd.（Japan）
• Stobbe Pharma GmbH（Germany）
• Celltainer Biotech BV（Netherlands）
• Foxx Life Sciences（US）
• Shanghai Lepure Biotech Co., Ltd.（China）

Global Bioprocess Containers Market size was valued at USD 2.10 billion in 2022 and is poised to grow from USD 2.63 billion in 2023 to USD 15.87 billion by 2031, growing at a CAGR of 25.20% during the forecast period (2024-2031).

The global bioprocess containers market has seen significant expansion in recent years. This growth is largely driven by the industry's shift towards single-use technologies, which enhance operational efficiency, reduce infection risks, and streamline biopharmaceutical production processes. Single-use bioprocess containers, also known as disposable bags, have become essential in the production of vaccines, biologics, and other pharmaceuticals. Their increasing adoption is a major factor contributing to the market's expansion. Additionally, the demand for flexible and cost-effective solutions further fuels market growth. The market is expected to continue evolving, supported by advancements in biopharmaceutical manufacturing technologies and a rise in research and development activities. Strategic moves such as mergers and acquisitions, collaborations, and the expansion of product lines and geographic presence by key players are also pivotal in shaping the market. These developments are crucial for maintaining competitive advantage and driving ongoing growth in the bioprocess containers sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioprocess Containers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioprocess Containers Market Segmental Analysis

Global Bioprocess Containers Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into 2D Bioprocess Containers, 3D Bioprocess Containers, and Other Containers & Accessories. Based on Application, the market is segmented into Upstream Processes, Downstream Processes, Process Development. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Bioprocess Containers Market

A major driver in the global bioprocess containers market is technological innovation. The ongoing evolution and integration of advanced technologies are significantly boosting the market. Innovations in design, materials, and manufacturing methods of bioprocess containers enhance flexibility, scalability, and efficiency in manufacturing processes. These advancements enable the industry to address the growing demand for biologics and other biopharmaceuticals more effectively. Furthermore, these technological improvements not only increase overall productivity in bioprocessing but also help manage impurity risks and enhance cost-effectiveness. As a result, the continuous advancement in bioprocess container technologies is driving their widespread adoption across the industry.

Restraints in the Global Bioprocess Containers Market

Currently, plastic is considered one of the most significant threats to the future, primarily due to its environmental impact. A major constraint for the bioprocess containers market is the environmental burden associated with plastic waste from single-use containers. This accumulation of plastic contributes to pollution and poses challenges for the industry to find more sustainable alternatives. Increasing regulatory pressures and a heightened focus on corporate social responsibility are prompting companies to address these environmental concerns. As a result, there is a growing need for the development and adoption of more eco-friendly solutions. Until such sustainable alternatives are widely implemented, the extensive use of bioprocess containers may be limited by these environmental and regulatory constraints.

Market Trends of the Global Bioprocess Containers Market

A prominent trend in the global bioprocess containers market is the adoption of smart manufacturing technologies and Industry 4.0. Biopharmaceutical companies are increasingly utilizing data-driven approaches, connectivity, and automation to boost the reliability and efficiency of their production processes. This integration enhances process visibility and quality, while also facilitating predictive maintenance to minimize downtime and improve overall operational performance. As the industry undergoes digital transformation, the incorporation of these advanced technologies into the production of bioprocess containers is becoming essential. This shift not only drives market growth but also significantly enhances the effectiveness of manufacturing operations by leveraging the benefits of smart technologies.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Supply chain Analysis
• Case study Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Bioprocess Containers Market by Type

• Market Overview
• 2D Bioprocess Containers
• 3D Bioprocess Containers
• Other Containers & Accessories

Bioprocess Containers Market by Application

• Market Overview
• Upstream Processes
• Downstream Processes
• Process Development

Bioprocess Containers Market by End User

• Market Overview
• Pharmaceutical & Biopharmaceutical Companies
• Contract Research Organizations & Contract Manufacturing Organizations
• Academic & Research Institutes

Bioprocess Containers Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Sartorius Stedim Biotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saint-Gobain (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Entegris, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meissner Filtration Products, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antylia Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flexbiosys Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Michelin Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABEC, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellexus (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keofitt A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujimori Kogyo Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cesco Bioengineering Co., Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solida Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Satake Chemical Equipment Mfg., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stobbe Pharma GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celltainer Biotech BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foxx Life Sciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Lepure Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments